// App-Quantinova.ai

10541 : Detection and HER2 expression of circulating tumor cells in advanced gastric cancer patients.

Researchers

Presenter

  • Satoshi Matsusaka

Principal Investigators

  • Keisho Chin

  • Mariko Ogura

  • Yasuhito Terui

  • Kiyohiko Hatake

  • Mitsukuni Suenaga

  • Eiji Shinozaki

  • Nobuyuki Mizunuma

  • Takeshi Sano

  • Toshiharu Yamaguchi

  • Noriko Yamamoto

  • Yuichi Ishikawa

  • Yuji Mishima

Medical Centers

  • Division of Gastroenterological Surgery, Gastroenterology Center, Cancer Institute Hospital, Tokyo, Japan

  • Department of Medical Oncology of Cancer Institute Hospital, Clinical Chemotherapy, Cancer Chemotherapy Center of Japanese Foundation for Cancer Research, Tokyo, Japan

  • Department of Gastroenterology, Cancer Institute Hospital, Tokyo, Japan

  • The Cancer Institute Hospital, Tokyo, Japan

  • Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

  • Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan

  • Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

  • Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gastric Cancer

Biomarkers

  • Circulating tumor cells

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved